Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Mandelic Acid. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN101134943B reveals a novel Alcaligenes strain for >99.9% e.e. mandelic acid. Discover cost-effective biocatalytic solutions for pharmaceutical manufacturing.
Patented chloroform-based route for o-chloromandelic acid ensures high purity and cost reduction in API intermediate manufacturing for global supply chains.
Patent CN102660625A details enzymatic synthesis for high purity. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing globally.
Patent CN101417942B reveals high-purity synthesis route. Enables cost reduction in pharma intermediate manufacturing with scalable chromatography separation.
Patent CN113354534B details a green synthesis route for D-FMC. This method ensures high purity and reduces costs for pharmaceutical intermediates manufacturing supply chains.
Patent CN105755095B details enzymatic synthesis of chiral hydroxy acids. Offers cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN100385007C details a microbial method for (R)-mandelic acid using Brevibacterium flavum, offering high optical purity and scalable biocatalysis for pharma intermediates.
Novel electrophilic substitution route for 3-hydroxymethyl-4-hydroxymandelic acid. Reduces steps, lowers cost, ensures high purity for asthma medication supply chains.
Novel resolution method using L-Tyrosine methyl ester achieves >99.5% ee. Cost-effective, scalable process for pharmaceutical intermediates.
Novel one-step synthesis patent CN103319335B offers high purity greater than 99 percent. Reduces equipment investment and enables green manufacturing for pharmaceutical intermediates.
Patent CN114315866B enables eco-friendly levamisole hydrochloride production via L-mandelic acid route eliminating chiral catalysts and reducing waste for enhanced supply chain resilience.
Patent CN114315866B enables eco-friendly levamisole hydrochloride production without hazardous reagents, ensuring scalable supply and cost reduction for pharmaceutical manufacturers.